Mechanically, we showed that PBX3 enhances mesenchymal phenotype of GBM through a positive feedback loop involving activation of MEK, ERK1/2, c-myc, and LIN28, leading to inhibition of the let-7b expression and upregulation of its targets. Here, MAP2K7 is linked to glioblastoma.